pharma · Cystic Fibrosis · Multiple Sclerosis · RARE
Ultragenyx UK
Ultragenyx UK Limited
Ultragenyx UK clinical programs — 22 development programs from ClinicalTrials.gov with phase, modality, indication, and trial identifiers.
Company details
- Status
- Public
- HQ
- Newcastle upon tyne, NE128RL, GB, NOVATO, CA
- Founded
- 2024
- Employees
- 2
- Programs
- 201
- Drugs
- 168
- Patents
- 23
Ultragenyx UK projects
22 ClinicalTrials.gov programs sponsored by Ultragenyx UK.
Ultragenyx UK has 22 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.
Clinical programs
-
AS/BW/ENE-21/0003
Ultragenyx UK Limited
Latrodectism
1 trial -
Acetazolamide
Ultragenyx UK Limited
Andersen-Tawil Syndrome
1 trial -
Ad5-CB-CFTR
Ultragenyx UK Limited
Cystic Fibrosis
1 trial -
Burosumab
Ultragenyx UK Limited
Cutaneous Skeletal Hypophosphatemia Syndrome (CSHS)
1 trial -
CRD-TMH-001
Ultragenyx UK Limited
Duchenne Muscular Dystrophy
1 trial -
H5.001CBCFTR
Ultragenyx UK Limited
Cystic Fibrosis
1 trial -
ManNAc
Ultragenyx UK Limited
Hereditary Inclusion Body Myopathy (HIBM)
1 trial -
N-acetylcysteine
Ultragenyx UK Limited
Parkinson's Disease
1 trial -
Sargramostim
Ultragenyx UK Limited
Autoimmune Pulmonary Alveolar Proteinosis
1 trial -
Sialic Acid Extended Release (SA-ER) Tablets
Ultragenyx UK Limited
Hereditary Inclusion Body Myopathy (HIBM)
1 trial -
Triheptanoin
Ultragenyx UK Limited
Pyruvate Dehydrogenase Complex Deficiency
1 trial -
Triheptanoin
Ultragenyx UK Limited
Glycogen Storage Disease Type I
1 trial -
amifostine
Ultragenyx UK Limited
Fanconi's Anemia
1 trial -
anti-thymocyte globulin
Ultragenyx UK Limited
Systemic Lupus Erythematosus
1 trial -
anti-thymocyte globulin
Ultragenyx UK Limited
Multiple Sclerosis
1 trial -
colchicine
Ultragenyx UK Limited
Cirrhosis
1 trial -
cyclophosphamide
Ultragenyx UK Limited
Multiple Sclerosis
1 trial -
filgrastim
Ultragenyx UK Limited
Fanconi's Anemia
1 trial -
gene therapy
Ultragenyx UK Limited
Familial Hypercholesterolemia
1 trial -
monoclonal antibody M-T412
Ultragenyx UK Limited
Multiple Sclerosis
1 trial -
recombinant adenovirus containing the ornithine transcarbamylase gene
Ultragenyx UK Limited
Ornithine Transcarbamylase Deficiency Disease
1 trial -
von Willebrand factor
Ultragenyx UK Limited
Von Willebrand's Disease
1 trial
Frequently asked questions
How many clinical projects does Ultragenyx UK have?
22 published programs are linked to this sponsor in our ClinicalTrials.gov index.
Is this the complete company pipeline?
This directory lists published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.